Product Information
PROCRIT 4,000 UNIT/ML VIAL is a brand product labeled by Janssen Products LP, priced at $104.2817 per ML under NDC 59676030401. Its NADAC has been published 450 times since Nov 28, 2013.
Strength
4000 [iU]/mL
Manufacturer
Janssen Products LPNDC
59676030401
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
EPOETINApproval Type
Biologic (BLA)
FDA Application
BLA103234On Market Since
6/1/1989
Pharmacological Classes
Price Statistics
The NADAC for PROCRIT 4,000 UNIT/ML VIAL has been published 450 times since Nov 28, 2013, and over the history we have for it it has risen 31.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $104.2817 per ML |
|---|---|
| All-time high | $104.8743 (Jan 15, 2020) |
| All-time low | $79.5826 (Nov 28, 2013) |
| 52-week high | $104.3231 |
| 52-week low | $103.9726 |
| Median price | $100.9407 |
| Average price | $96.3945 |
| Largest weekly change | +4.9% (Jan 10, 2018) |
| Weeks tracked | 450 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Erythropoietin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Products LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythropoietin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Erythropoiesis-stimulating Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCRIT 4,000 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for PROCRIT 4,000 UNIT/ML VIAL, manufactured by Janssen Products LP, is $104.2817 per ML (NDC 59676030401), effective Sep 30, 2026.
How has the price of PROCRIT 4,000 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for PROCRIT 4,000 UNIT/ML VIAL has risen 31.0%. It has been tracked across 450 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROCRIT 4,000 UNIT/ML VIAL?
Since Nov 28, 2013, the NADAC for PROCRIT 4,000 UNIT/ML VIAL has ranged from a low of $79.5826 (Nov 28, 2013) to a high of $104.8743 (Jan 15, 2020), with a median of $100.9407 per ML.
Are there cheaper alternatives to PROCRIT 4,000 UNIT/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of PROCRIT 4,000 UNIT/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROCRIT 4,000 UNIT/ML VIAL?
PROCRIT 4,000 UNIT/ML VIAL (NDC 59676030401) is labeled by Janssen Products LP, and CMS classifies it as a brand product.